Heparin effects on plasma lysolecithin formation and platelet aggregation.

[1]  V. Kakkar,et al.  Low-doses of heparin in the prevention of deep vein thrombosis. , 1971, Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften.

[2]  E. Besterman,et al.  Inhibition of platelet aggregation by lysolecithin. , 1971, Atherosclerosis.

[3]  H. Williams,et al.  Prevention of postoperative deep-vein thrombosis with perioperative subcutaneous heparin. , 1971, Lancet.

[4]  W. W. Slack,et al.  Effect of small doses of heparin on platelet adhesiveness and lipoprotein-lipase activity before and after surgery. , 1971, Lancet.

[5]  P. Elsbach,et al.  Lysolecithin metabolism by human platelets. , 1971, Blood.

[6]  F. Kunz,et al.  Plasma phospholipids in type IV hyperlipoproteinemia. , 1970, Atherosclerosis.

[7]  O. Vikrot,et al.  Acute myocardial infarction and plasma phospholipid levels. , 2009, Acta medica Scandinavica.

[8]  O. Vikrot,et al.  Increased lecithinase activity after heparin administration. , 2009, Acta medica Scandinavica.

[9]  L. Zieve,et al.  Similarities between Postheparin Lipase and Postheparin Phospholipase , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[10]  J. Glomset,et al.  The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.

[11]  G. Ruhenstroth-bauer,et al.  Nachweis, Anreicherung und Charakterisierung eines Lysolecithin freisetzenden Enzyms aus menschlichem Serum , 1968 .

[12]  P. Elsbach.  Metabolism of lysophosphatidyl ethanolamine and lysophosphatidyl choline by homogenates of rabbit polymorphonuclear leukocytes and alveolar macrophages. , 1967, Journal of lipid research.

[13]  J. Barboriak,et al.  Blood platelets and heparin-induced lipolytic activity. , 1967, The American journal of physiology.

[14]  E. Bierman,et al.  Post-heparin serum lecithinase in man and its positional specificity. , 1967, Journal of lipid research.

[15]  P. Elsbach,et al.  Metabolism of phospholipids by polymorphonuclear leukocytes. , 1965, Biochimica et biophysica acta.

[16]  L. van Deenen,et al.  Metabolism of red-cell lipids. 3. Pathways for phospholipid renewal. , 1965, Biochimica et biophysica acta.

[17]  L. van Deenen,et al.  Metabolism of red-cell lipids. II. Conversions of lysophosphoglycerides. , 1965, Biochimica et biophysica acta.

[18]  L. Mcdonald,et al.  LIPOPROTEIN-LIPASE LEVELS AND PLATELET STICKINESS IN PATIENTS WITH ISCHAEMIC HEART-DISEASE AND IN CONTROLS, DISTINGUISHING THOSE WITH AN AFFECTED FIRST-DEGREE RELATIVE. , 1964, Lancet.

[19]  J. Glomset,et al.  SOME PROPERTIES OF A CHOLESTEROL ESTERIFYING ENZYME IN HUMAN PLASMA. , 1964, Biochimica et biophysica acta.

[20]  L. Zieve,et al.  POST-HEPARIN PHOSPHOLIPASE. , 1964, Journal of lipid research.

[21]  D. Robinson.  THE CLEARING FACTOR LIPASE AND ITS ACTION IN THE TRANSPORT OF FATTY ACIDS BETWEEN THE BLOOD AND TISSUES. , 1963, Advances in lipid research.

[22]  J. French,et al.  Heparin, the clearing factor lipase, and fat transport. , 1960, Pharmacological reviews.

[23]  G. R. Bartlett.  Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.

[24]  H. Wright,et al.  Changes in the adhesiveness of blood platelets following parturition and surgical operations , 1942 .